Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Apr 23, 2024
Ipsen Partners with Skyhawk Therapeutics for RNA-Focused Research in Rare Neurological Disorders Ipsen and Skyhawk Therapeutics have entered into an exclusive global partnership to explore and create new small molecules that can influence RNA for rare neurological conditions. Under this agreement, Ipsen has the ...
Read More...
Feb 07, 2024
As we step into the crisp corridors of 2024, the healthcare landscape unfolds a compelling saga of mergers, strategic funding, and transformative acquisitions. In this month-by-month analysis, we delve into the intricate tapestry of industry dynamics, exploring the impactful maneuvers that are shaping the healthcar...
Read More...
Sep 21, 2022
Technological advancement is bringing in a new frontier in the healthcare segment with innovative tools and resourceful applications. With each passing day, it unlocks new mysteries and scales greater heights toward solving several underlying challenges. Now moving forward, how fascinating it will be if someone tel...
Read More...
Jun 15, 2022
Over the last decade, various technologies, after being evaluated rigorously, have exhibited competence in treating mental health by becoming an extension of the already present care models. Today, the patient or user can now download a clinical-grade app on the phone, tablet, or computer and use it as a reliable m...
Read More...
May 05, 2022
GE Healthcare and Medtronic Collaborated to Meet the Increasing Need for Outpatient Care On April 28, 2022, GE Healthcare and Medtronic entered into a collaboration to provide patients, clinicians, and payers seeking more choices of excellent care, inside and outside of the traditional hospital without compromis...
Read More...
Mar 10, 2022
Bioventus Receives 501(k) Clearance for StimRouter Pain Management Device On March 1, 2022, the US Food and Drug Administration (FDA) gave Bioventus' StimRouter Neuromodulation System 510(k) approval. The next-generation pain treatment device is intended to treat chronic pain caused by peripheral nerves, ex...
Read More...
Aug 04, 2021
Neurological Disorders are one of the most leading causes of injuries, death, and disability. Over more than 600 Neurological Disorders are believed to affect millions of people worldwide. These disorders have a deep impact on the patients, their families, and society at large. As per the systematic analysis for th...
Read More...
Jul 23, 2021
Neurological disorders are one of the major causes of death and disability across the globe. As per the figures published in The Lancet journal for the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016, neurological disorders accounted for DALYs, which were 276 million. The mortality and morbid...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper